secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envista Holdings Corp (NVST)
CIK:        0001757073
Form:       8-K
Filed at:   2022-08-03T23:59:59+00:00
Accession:  0001757073-22-000086
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envista Q2 sales $645.8M (+1.3%), core sales +4.0%; adj EPS $0.48; guidance revised to mid-single digits growth
--------------------------------------------------------------------------------

- Sales $645.8M (+1.3% YoY), core sales growth 4.0%; net income $44.5M ($0.25 diluted EPS).
- Adjusted net income $86.0M, adjusted EPS $0.48 (vs $0.46 in Q2 2021); adjusted EBITDA $126.9M, margin 19.7%.
- FY 2022 guidance: core sales growth revised to mid-single digits; maintains adjusted EBITDA margin target of 20%.
- Closed acquisitions of Carestream Dental's IOS business (Q2) and Osteogenics Regenerative Solutions (July).
- Cites headwinds: supply chain disruptions, inflation, geopolitical uncertainties, China COVID lockdown.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757073/000175707322000086/0001757073-22-000086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757073/000175707322000086/nvst-20220803.htm
  HTML page:      https://secwatch.observer/filing/0001757073-22-000086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer